1. Vitamin D Related/Nuclear Receptor Metabolic Enzyme/Protease
  2. Androgen Receptor Endogenous Metabolite
  3. DHEA

DHEA  (Synonyms: 脱氢表雄酮; Prasterone; Dehydroisoandrosterone; Dehydroepiandrosterone)

目录号: HY-14650 纯度: 99.93%
COA 产品使用指南

DHEA (Prasterone) 是最丰富的类固醇激素之一。 DHEA通过多种信号传导途径介导其作用,并通过转化成雄激素和雌激素衍生物(例如,雄激素,雌激素,7α和7β DHEA (Prasterone),以及7α和7β表雄甾酮衍生物)通过其特异性受体起作用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

DHEA Chemical Structure

DHEA Chemical Structure

CAS No. : 53-43-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥550
In-stock
100 mg ¥500
In-stock
250 mg ¥1000
In-stock
500 mg ¥1600
In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Customer Review

MCE 顾客使用本产品发表的 26 篇科研文献

  • 生物活性

  • 实验参考方法

  • 纯度 & 产品资料

  • 参考文献

生物活性

DHEA (Prasterone) is one of the most abundant steroid hormones. DHEA (Prasterone) mediates its action via multiple signaling pathways involving specific membrane receptors and via transformation into androgen and estrogen derivatives (e.g., androgens, estrogens, 7α and 7β DHEA, and 7α and 7β epiandrosterone derivatives) acting through their specific receptors.

IC50 & Target

Human Endogenous Metabolite

 

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A-431 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
[PMID: 25456391]
A-431 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
[PMID: 25456391]
A549 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
A549 IC50
47.8 μM
Compound: DHEA
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
[PMID: 25456391]
A549 IC50
47.8 μM
Compound: DHEA
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
[PMID: 25456391]
CHO EC50
3.33 μM
Compound: 49
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
[PMID: 18307294]
DU-145 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
HCT-116 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
HEK293 EC50
> 10 μM
Compound: 19
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
[PMID: 24928400]
HEK-293T IC50
24.9 μM
Compound: 1, DHEA, dehydroepiandrosterone
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
[PMID: 22506561]
HeLa IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
[PMID: 25456391]
HeLa IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
[PMID: 25456391]
HepG2 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
[PMID: 25456391]
HepG2 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
[PMID: 25456391]
HL-60 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
HL-60 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
[PMID: 26866967]
HT-29 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
[PMID: 25456391]
HT-29 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
[PMID: 25456391]
HT-29 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
J774.2 CC50
198.17 μM
Compound: 1a; DHEA
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
[PMID: 34571489]
Jurkat IC50
46.5 μM
Compound: DHEA
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
[PMID: 26866967]
LNCaP IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
[PMID: 25456391]
LNCaP IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
[PMID: 25456391]
LNCaP IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
MCF7 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
MCF7 IC50
> 200 μM
Compound: DHEA
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
[PMID: 23880359]
MCF7 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
[PMID: 25456391]
MCF7 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
[PMID: 25456391]
MCF7 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
MDA-MB-231 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
PC-12 IC50
0.29 nM
Compound: DHEA
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
[PMID: 19845386]
PC-12 IC50
1.65 nM
Compound: DHEA
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
[PMID: 19845386]
SMMC-7721 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
SW480 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
T47D IC50
2.55 μM
Compound: DHEA
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
体外研究
(In Vitro)

DHEA (Prasterone) is an effective antiapoptotic factor, reversing the serum deprivation-induced apoptosis in prostate cancer cells (DU145 and LNCaP cell lines) as well as in colon cancer cells (Caco2 cell line). DHEA (Prasterone) significantly reduces serum deprivation-induced apoptosis in all 3 cancer cell types, quantitated with the APOPercentage assay (apoptosis is reduced from 0.587±0.053 to 0.142±0.0016 or 0.059±0.002 after treatment for 12 hours with DHEA or NGF, respectively; n=3, P<0.01), and by flow cytometry analysis (FACS) for DU145 cells. The antiapoptotic effect of DHEA is dose dependent with an EC50 at nanomolar concentrations (EC50: 11.2±3.6 nM and 12.4±2.2 nM in DU145 and Caco2 cells, respectively)[1]. DHEA (Prasterone) is the principal sex steroid precursor in humans and can be converted directly to androgens. DHEA (Prasterone) (≥1 μM) causes a dose-dependent inhibition of Chub-S7 proliferation, as assessed by thymidine incorporation assays. DHEA (Prasterone) treatment inhibits expression of the key glucocorticoid-regulating genes H6PDH (≥100 nM) and HSD11B1 (≥1 μM) in differentiating preadipocytes in a dose-dependent manner. In keeping with this finding, DHEA (Prasterone) treatment (≥1 μM) results in a marked reduction in 11β-HSD1 oxoreductase activity (≥1 μM) and a concurrent increase in dehydrogenase activity at the highest DHEA dose used (25 μM DHEA) in differentiated adipocytes[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

DHEA (Prasterone) in the diet (0.45 % w/w) of male B6 mice (groups of five mice) treated for 8 weeks led to significant decreases in body temperature compared with mice fed the control AIN-76A diet. A similar comparison indicated that control and pair-fed mice are also significantly different. Animals fed DHEA (Prasterone) have significantly lower temperatures than mice fed the control diet 26/29 times tested; mice pair fed to those on the DHEA (Prasterone) diet are less affected, with 8/29 values significantly lower than in mice fed AIN-76A ad libitum. The temperatures of mice fed DHEA (Prasterone) or pair fed to DHEA (Prasterone) are significantly different 21/29 times tested. Body weights are significantly greater in mice fed the control diet than in mice fed DHEA or pair fed to DHEA (Prasterone). Food intake (grams per day) from cages are averaged for each week (n=7), except for Week 9 (n=3). The amount of food intake is significantly decreased in mice fed DHEA (Prasterone). By design, mice pair fed to DHEA (Prasterone) ate about the same amount. Thus, it appears that DHEA (Prasterone) reduces body temperature by food restriction and by a separate mechanism[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

288.42

Formula

C19H28O2

CAS 号
性状

固体

颜色

White to off-white

中文名称

脱氢表雄酮;去氢表雄酮;脱氢表雄甾酮;脱氢异雄酮;反式-脱氢异雄甾酮;反式-脱氢雄甾酮;脱氢表雄至素酮

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
溶解性数据
细胞实验: 

DMSO 中的溶解度 : 50 mg/mL (173.36 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

Ethanol 中的溶解度 : 40 mg/mL (138.69 mM; 超声助溶 (<60°C))

H2O 中的溶解度 : < 0.1 mg/mL (insoluble)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.4672 mL 17.3358 mL 34.6717 mL
5 mM 0.6934 mL 3.4672 mL 6.9343 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验:

请根据您的 实验动物和给药方式 选择适当的溶解方案。

以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 方案 一

    请依序添加每种溶剂: 10% DMSO    90% Corn Oil

    Solubility: ≥ 2.5 mg/mL (8.67 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液,此方案实验周期在半个月以上的动物实验酌情使用。

    1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

  • 方案 二

    请依序添加每种溶剂: 10% EtOH    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (8.67 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 EtOH 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中,混合均匀。

    2 g SBE-β-CD(磺丁基醚 β-环糊精)粉末定容于 10 mL 的生理盐水中,完全溶解至澄清透明。

以下溶解方案,请直接配制工作液。建议现用现配,在短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比; 如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。

  • 方案 一

    请依序添加每种溶剂: Corn Oil

    Solubility: 10 mg/mL (34.67 mM); 澄清溶液; 超声助溶

  • 方案 二

    请依序添加每种溶剂: 15% Cremophor EL    85% Saline

    Solubility: 25 mg/mL (86.68 mM); 悬浊液; 超声助溶

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
请输入您的动物体内配方组成:
%
DMSO +
+
%
Tween-80 +
%
Saline
如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
计算结果
工作液所需浓度 : mg/mL
储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。
您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
连续给药周期超过半月以上,请谨慎选择该方案。
请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
纯度 & 产品资料

纯度: 99.93%

参考文献
Cell Assay
[2]

Chub-S7 preadipocytes and human primary preadipocytes are seeded into a 24-well plate at densities 1×105 and 2.5×105 respectively. Following overnight culture, medium is supplemented with DHEA, androstenediol, or DHEA (Prasterone) (0-100 μM). Following 24-, 48-, or 72 h incubation, cell proliferation is assessed by incubation with radiolabeled thymidine (0.2 μCi/well) for the final 6 h of culture. Proteins are precipitated with TCA, and cells are scraped in NaOH. The respective content of radiolabeled nuclear material in the resulting lysates is analyzed by scintillation counting[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration
[3]

Mice[3]
Mice are fed Purina Lab Chow until the start of experiments (Day 0). Groups of five mice are then fed pelleted AIN-76A diet containing either no additive or DHEA (0.45% w/w) between 0900 and 1000 hr. Diets are stored at 4°C for no longer than six months to maintain optimal activity. Mice are given the diets ad libitum, except for mice that are pair fed to mice treated with DHEA (Prasterone). The amounts of AIN-76A diet the pair-fed mice received are determined by the weight of food consumed by the DHEA-fed mice on a daily basis. Body weights (grams) are measured at different time points starting at Day 1 and ending at Day 59. Daily food intakes (grams per day) are determined by weighing the food consumed per cage of five mice. The mean±SEM values are calculated for weeks 1 to 8 (n=7); week 9 had only 3 days.

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
Ethanol / DMSO 1 mM 3.4672 mL 17.3358 mL 34.6717 mL 86.6791 mL
5 mM 0.6934 mL 3.4672 mL 6.9343 mL 17.3358 mL
10 mM 0.3467 mL 1.7336 mL 3.4672 mL 8.6679 mL
15 mM 0.2311 mL 1.1557 mL 2.3114 mL 5.7786 mL
20 mM 0.1734 mL 0.8668 mL 1.7336 mL 4.3340 mL
25 mM 0.1387 mL 0.6934 mL 1.3869 mL 3.4672 mL
30 mM 0.1156 mL 0.5779 mL 1.1557 mL 2.8893 mL
40 mM 0.0867 mL 0.4334 mL 0.8668 mL 2.1670 mL
50 mM 0.0693 mL 0.3467 mL 0.6934 mL 1.7336 mL
60 mM 0.0578 mL 0.2889 mL 0.5779 mL 1.4447 mL
80 mM 0.0433 mL 0.2167 mL 0.4334 mL 1.0835 mL
100 mM 0.0347 mL 0.1734 mL 0.3467 mL 0.8668 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
DHEA
目录号:
HY-14650
需求量: